Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

Nature Medicine

Volumn 8, Issue 8, 2002, Pages 864-871

  Hoshijima, Masahiko ^a   Ikeda, Yasuhiro ^a   Iwanaga, Yoshitaka ^a   Minamisawa, Susumu ^a   Date, Moto O ^a   Gu, Yusu ^a   Iwatate, Mitsuo ^a   Li, Manxiang ^b   Wang, Lili ^c   Wilson, James M ^c   Wang, Yibin ^b   Ross, John ^a   Chien, Kenneth R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLAMBAN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HAMSTER; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEMODYNAMICS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; VIRUS RECOMBINANT;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; ANIMALS; AORTA; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIAC OUTPUT, LOW; CELLS, CULTURED; CRICETINAE; DEPENDOVIRUS; DISEASE PROGRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMODYNAMIC PROCESSES; HUMANS; LIVER; MICE; MOLECULAR SEQUENCE DATA; MUTATION; MYOCARDIUM; SARCOPLASMIC RETICULUM; SEQUENCE ALIGNMENT;

ADENO-ASSOCIATED VIRUS; ANIMALIA; CRICETINAE;

EID: 0036341380     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm739     Document Type: Article

References (38)

1. Stress pathways and heart failure
2. Signaling pathways for cardiac hypertrophy and failure
3. Mixed signals in heart failure: Cancer rules
4. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
5. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
6. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation
7. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
8. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
9. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure
10. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
11. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction
12. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters
13. Muscular dystrophies and the dystrophin-glycoprotein complex
14. Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer
15. 2+-ATPase
16. Phospholamban: Protein structure, mechanism of action, and role in cardiac function
17. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a
18. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition
19. Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity
20. Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery
21. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival
22. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors
23. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO- 2 hamsters
24. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene
25. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
26. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
27. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
28. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
29. The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers
30. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart
31. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
32. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver
33. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
34. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
35. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column
36. 2+ transport
37. 2+-pump stimulation
38. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates